Discordance between Primary Breast Cancer and Ipsilateral Breast Cancer Tumor Recurrence as a Function of Distance
暂无分享,去创建一个
M. Beckmann | S. Jud | C. Hack | W. Adler | Reinhard Hatko | J. Emons | F. Heindl | C. Preuss | Bianca Lauterbach
[1] M. Lux,et al. Update Breast Cancer 2020 Part 1 – Early Breast Cancer: Consolidation of Knowledge About Known Therapies , 2020, Geburtshilfe und Frauenheilkunde.
[2] M. Lux,et al. Interdisciplinary Screening, Diagnosis, Therapy and Follow-up of Breast Cancer. Guideline of the DGGG and the DKG (S3-Level, AWMF Registry Number 032/045OL, December 2017) – Part 2 with Recommendations for the Therapy of Primary, Recurrent and Advanced Breast Cancer , 2018, Geburtshilfe und Frauenheilkunde.
[3] M. Lux,et al. Interdisciplinary Screening, Diagnosis, Therapy and Follow-up of Breast Cancer. Guideline of the DGGG and the DKG (S3-Level, AWMF Registry Number 032/045OL, December 2017) – Part 1 with Recommendations for the Screening, Diagnosis and Therapy of Breast Cancer , 2018, Geburtshilfe und Frauenheilkunde.
[4] Tae Hyun Kim,et al. Locoregional Recurrence by Tumor Biology in Breast Cancer Patients after Preoperative Chemotherapy and Breast Conservation Treatment , 2016, Cancer research and treatment : official journal of Korean Cancer Association.
[5] Se Kyung Lee,et al. Independent Prognostic Factors for Overall Survival after Salvage Operation for Ipsilateral Breast Tumor Recurrence Following Breast-Conserving Surgery , 2015, Journal of breast cancer.
[6] T. Shien,et al. Change in estrogen receptor, HER2, and Ki-67 status between primary breast cancer and ipsilateral breast cancer tumor recurrence. , 2015, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[7] A. Goldhirsch,et al. A meta-analysis of oestrogen receptor, progesterone receptor and human epidermal growth factor receptor 2 discordance between primary breast cancer and metastases. , 2014, European journal of cancer.
[8] R. Gelber,et al. Chemotherapy for isolated locoregional recurrence of breast cancer (CALOR): a randomised trial. , 2014, The Lancet. Oncology.
[9] M. Lux,et al. Isolated Loco-Regional Recurrence of Breast Cancer – Established andInnovative Therapy Concepts , 2013 .
[10] M. Bani,et al. Prognostic relevance of Ki-67 in the primary tumor for survival after a diagnosis of distant metastasis , 2013, Breast Cancer Research and Treatment.
[11] M. Kerin,et al. Locoregional recurrence after breast cancer surgery: a systematic review by receptor phenotype , 2012, Breast Cancer Research and Treatment.
[12] P. Watson,et al. Clinicopathologic factors of the recurrent tumor predict outcome in patients with ipsilateral breast tumor recurrence , 2011, Cancer.
[13] N. Wolmark,et al. Progress on BIG 1-02/IBCSG 27-02/NSABP B-37, a Prospective Randomized Trial Evaluating Chemotherapy after Local Therapy for Isolated Locoregional Recurrences of Breast Cancer , 2008, Annals of Surgical Oncology.
[14] A. Taghian,et al. Patterns of locoregional failure in patients with operable breast cancer treated by mastectomy and adjuvant chemotherapy with or without tamoxifen and without radiotherapy: results from five National Surgical Adjuvant Breast and Bowel Project randomized clinical trials. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[15] J. Forbes,et al. Risk factors for locoregional recurrence among breast cancer patients: results from International Breast Cancer Study Group Trials I through VII. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[16] S. Singletary,et al. Classifying local disease recurrences after breast conservation therapy based on location and histology , 2002, Cancer.
[17] H. Rauschecker,et al. Systemic therapy for treating locoregional recurrence in women with breast cancer. , 2001, The Cochrane database of systematic reviews.
[18] G. Hortobagyi,et al. Locoregional recurrence patterns after mastectomy and doxorubicin-based chemotherapy: implications for postoperative irradiation. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[19] R. Gray,et al. Locoregional failure 10 years after mastectomy and adjuvant chemotherapy with or without tamoxifen without irradiation: experience of the Eastern Cooperative Oncology Group. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[20] E Marubini,et al. Local recurrences and distant metastases after conservative breast cancer treatments: partly independent events. , 1995, Journal of the National Cancer Institute.
[21] D. Fischer,et al. Prognosis following local recurrence in the conservatively treated breast cancer patient. , 1991, International journal of radiation oncology, biology, physics.
[22] J. Jacquemier,et al. Local recurrence after breast‐conserving surgery and radiotherapy. Frequency, time course, and prognosis , 1989, Cancer.
[23] R Core Team,et al. R: A language and environment for statistical computing. , 2014 .
[24] H. Tsukuma,et al. Ipsilateral breast tumor recurrence (IBTR) after breast‐conserving treatment for early breast cancer , 2006, Cancer.
[25] E. Touboul,et al. Local recurrences and distant metastases after breast-conserving surgery and radiation therapy for early breast cancer. , 1999, International journal of radiation oncology, biology, physics.
[26] D. Schultz,et al. Breast recurrence following conservative surgery and radiation: patterns of failure, prognosis, and pathologic findings from mastectomy specimens with implications for treatment. , 1990, International journal of radiation oncology, biology, physics.